Recent reports of Apple's potential acquisition of Perplexity AI have ignited industry speculation despite the startup's firm denial of any ongoing discussions. Internal deliberations within Apple, led by M&A chief Adrian Perica and services head...
Colombian billionaire Jaime Gilinski Bacal, Metro Bank's controlling shareholder with a 52.87% stake, is actively exploring a sale of his position following unsolicited investor interest and a sustained share price recovery. This development comes...
Shell's swift denial of merger talks with BP marks a pivotal moment in energy sector consolidation, revealing deeper strategic realignments as oil giants navigate volatile markets. The proposed $80 billion acquisition would have created a $300...
Aon's landmark Global Transaction Solutions Claims Study reveals unprecedented activity in representations and warranties (R&W) insurance, with North American clients recovering a record $300 million in paid claims during 2024 alone—the highest...
As Europe undergoes its largest military buildup since the Cold War, The Carlyle Group is strategically positioning itself to capitalize on unprecedented public-private defense partnerships. The European Union's €800 billion "ReArm Europe"...
Recent reports of Apple's potential acquisition of Perplexity AI have ignited industry speculation despite the startup's firm denial of any ongoing discussions. Internal deliberations within Apple, led by M&A chief Adrian Perica and services head...
Colombian billionaire Jaime Gilinski Bacal, Metro Bank's controlling shareholder with a 52.87% stake, is actively exploring a sale of his position following unsolicited investor interest and a sustained share price recovery. This development comes...
Eli Lilly's acquisition of Verve Therapeutics for up to $1.3 billion marks a watershed moment in the convergence of gene editing and cardiovascular therapeutics. This deal, announced on June 17, 2025, positions Lilly at the forefront of developing...
In a landmark transaction reshaping India's pharmaceutical landscape, Torrent Pharmaceuticals announced the acquisition of KKR's 46.39% controlling stake in JB Chemicals & Pharmaceuticals for ₹11,917 crore ($1.4 billion), with the full equity...
Danone has significantly advanced its gut health research capabilities through the acquisition of The Akkermansia Company, a pioneer in next-generation probiotics and postbiotics. This strategic move enhances Danone's scientific portfolio with...
ProAssurance Corporation (NYSE: PRA) shareholders have delivered a decisive mandate for the company's acquisition by The Doctors Company, with over 99% of voting shares endorsing the $1.3 billion transaction that will create the nation's largest...
The $3.3 billion standoff between Surgery Partners and Bain Capital represents a defining moment in healthcare private equity, revealing fundamental tensions between short-term liquidity events and long-term value creation in the rapidly evolving...
Eli Lilly's acquisition of Verve Therapeutics for up to $1.3 billion marks a watershed moment in the convergence of gene editing and cardiovascular therapeutics. This deal, announced on June 17, 2025, positions Lilly at the forefront of developing...
In a landmark transaction reshaping India's pharmaceutical landscape, Torrent Pharmaceuticals announced the acquisition of KKR's 46.39% controlling stake in JB Chemicals & Pharmaceuticals for ₹11,917 crore ($1.4 billion), with the full equity...